JF
DGX icon

Jericho Financial’s Quest Diagnostics DGX Stock Holding History

Jericho Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Sell
1,622
-860
-35% -$169K 0.18% 37
2026
Q1 		$486K Sell
2,482
-140
-5% -$27.2K 0.31% 34
2025
Q4 		$455K Sell
2,622
-753
-22% -$137K 0.27% 35
2025
Q3 		$643K Sell
3,375
-195
-5% -$34.6K 0.39% 33
2025
Q2 		$641K Sell
3,570
-104
-3% -$18.1K 0.42% 33
2025
Q1 		$622K Sell
3,674
-236
-6% -$38.8K 0.45% 32
2024
Q4 		$590K Buy
+3,910
New +$608K 0.43% 32

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Jericho Financial's DGX Position: Q2 2026 in Review

Jericho Financial reduced its Quest Diagnostics (DGX) stake by 35% in Q2 2026, selling an estimated $169K and leaving 1,622 shares worth $344K. The position accounts for 0.18% of the portfolio, ranked #37.

Jericho Financial first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $643K in Q3 2025. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Jericho Financial held 1,622 shares of Quest Diagnostics worth $344K as of Q2 2026.
  • Jericho Financial sold 860 Quest Diagnostics shares in Q2 2026, an estimated $169K.
  • Quest Diagnostics made up 0.18% of Jericho Financial's portfolio in Q2 2026, its #37 holding.
  • Jericho Financial first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • Jericho Financial's Quest Diagnostics position peaked at $643K in Q3 2025.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Jericho Financial's 13F filing for Q2 2026, filed 13 Aug 2026.